Literature DB >> 18559413

Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements.

Karen L Margolis1, Robert Brzyski, Denise E Bonds, Barbara V Howard, Sarah Kempainen, Jennifer G Robinson, Monika M Safford, Lesley T Tinker, Lawrence S Phillips.   

Abstract

OBJECTIVE: Although diabetes is conveniently assessed by self-report, few validation studies have been performed. Therefore, we studied whether self-report of prevalent and incident diabetes in Women's Health Initiative (WHI) participants was concordant with other diagnostic evidence of diabetes. STUDY DESIGN AND
SETTING: A total of 161 808 postmenopausal women aged 50-79 were enrolled at 40 clinical centers in the U.S. in 1993-1998 and followed prospectively. At baseline, prevalent medication treated diabetes was defined as a self-report of physician diagnosis and treatment with insulin or oral antidiabetic drugs. During followup, incident treated diabetes was defined as a self-report of a new physician diagnosis of diabetes treated with insulin or oral drugs. Diabetes self-reports were compared with medication inventories and fasting glucose levels at baseline and during follow-up.
RESULTS: At baseline, self-reported treated diabetes was concordant with the medication inventory in 79% of clinical trial, and 77% of observational study participants. Self-reported incident treated diabetes was concordant with the medication inventory in 78% between baseline and Year 1 in the clinical trials, in 62% between Year 1 and Year 3 in the clinical trials, and in 72% between baseline and Year 3 in the observational study. Over similar periods, 99.9% of those who did not report treated diabetes had no oral antidiabetic drugs or insulin in the medication inventory. At baseline, about 3% not reporting diabetes had fasting glucose >126 mg/dl, and 88% of these subjects subsequently reported treated diabetes during 6.9 years of follow-up. LIMITATIONS: Incident self-reported diabetes treated by lifestyle alone was not determined in WHI. Medication inventories may have been incomplete and fasting glucose may have been lowered by treatment; therefore, concordance with self-reported treatment or fasting glucose > or = 126 may have been underestimated.
CONCLUSION: In the WHI, self-reported prevalent and incident diabetes was consistent with medication inventories, and a high proportion of those with undiagnosed diabetes subsequently reported diabetes treatment. Self-reports of ;treated diabetes' are sufficiently accurate to allow use in epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559413      PMCID: PMC2757268          DOI: 10.1177/1740774508091749

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  19 in total

1.  Implementation of the Women's Health Initiative study design.

Authors:  Garnet L Anderson; Joann Manson; Robert Wallace; Bernedine Lund; Dallas Hall; Scott Davis; Sally Shumaker; Ching-Yun Wang; Evan Stein; Ross L Prentice
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

2.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

3.  Physical activity and incidence of non-insulin-dependent diabetes mellitus in women.

Authors:  J E Manson; E B Rimm; M J Stampfer; G A Colditz; W C Willett; A S Krolewski; B Rosner; C H Hennekens; F E Speizer
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

4.  Diabetes trends in the U.S.: 1990-1998.

Authors:  A H Mokdad; E S Ford; B A Bowman; D E Nelson; M M Engelgau; F Vinicor; J S Marks
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

5.  Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.

Authors:  Yiqing Song; JoAnn E Manson; Lesley Tinker; Nader Rifai; Nancy R Cook; Frank B Hu; Gokhan S Hotamisligil; Paul M Ridker; Beatriz L Rodriguez; Karen L Margolis; Albert Oberman; Simin Liu
Journal:  Diabetes       Date:  2007-03-27       Impact factor: 9.461

6.  Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.

Authors: 
Journal:  Diabetes Care       Date:  1998-02       Impact factor: 19.112

7.  Comparing self-reported and physician-reported medical history.

Authors:  R Kehoe; S Y Wu; M C Leske; L T Chylack
Journal:  Am J Epidemiol       Date:  1994-04-15       Impact factor: 4.897

8.  The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants.

Authors:  Cheryl Ritenbaugh; Ruth E Patterson; Rowan T Chlebowski; Bette Caan; Lesley Fels-Tinker; Barbara Howard; Judy Ockene
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

9.  Prevalence of diabetes and impaired fasting glucose in adults--United States, 1999-2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-09-05       Impact factor: 17.586

10.  Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

View more
  163 in total

1.  Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative.

Authors:  Lesley F Tinker; Gloria E Sarto; Barbara V Howard; Ying Huang; Marian L Neuhouser; Yasmin Mossavar-Rahmani; Jeannette M Beasley; Karen L Margolis; Charles B Eaton; Lawrence S Phillips; Ross L Prentice
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

2.  Diabetes risk in older Mexican Americans: effects of language acculturation, generation and socioeconomic status.

Authors:  Aimee Afable-Munsuz; Steven E Gregorich; Kyriakos S Markides; Eliseo J Pérez-Stable
Journal:  J Cross Cult Gerontol       Date:  2013-09

3.  Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.

Authors:  Alan M Rathbun; Leslie R Harrold; George W Reed
Journal:  Clin Rheumatol       Date:  2014-08-27       Impact factor: 2.980

4.  Diabetes and risk of bladder cancer: evidence from a case-control study in New England.

Authors:  Todd MacKenzie; Michael S Zens; Assiamira Ferrara; Alan Schned; Margaret R Karagas
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

5.  Trends in estimated kidney function: the FINRISK surveys.

Authors:  Auni Juutilainen; Helena Kastarinen; Riitta Antikainen; Markku Peltonen; Veikko Salomaa; Jaakko Tuomilehto; Pekka Jousilahti; Jouko Sundvall; Tiina Laatikainen; Mika Kastarinen
Journal:  Eur J Epidemiol       Date:  2012-04       Impact factor: 8.082

6.  Dietary Manganese, Plasma Markers of Inflammation, and the Development of Type 2 Diabetes in Postmenopausal Women: Findings From the Women's Health Initiative.

Authors:  Jung Ho Gong; Kenneth Lo; Qing Liu; Jie Li; Shuiqing Lai; Aladdin H Shadyab; Chrisa Arcan; Linda Snetselaar; Simin Liu
Journal:  Diabetes Care       Date:  2020-04-15       Impact factor: 19.112

7.  Obesity and late-age survival without major disease or disability in older women.

Authors:  Eileen Rillamas-Sun; Andrea Z LaCroix; Molly E Waring; Candyce H Kroenke; Michael J LaMonte; Mara Z Vitolins; Rebecca Seguin; Christina L Bell; Margery Gass; Todd M Manini; Kamal H Masaki; Robert B Wallace
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

8.  All-cause, cardiovascular, and cancer mortality rates in postmenopausal white, black, Hispanic, and Asian women with and without diabetes in the United States: the Women's Health Initiative, 1993-2009.

Authors:  Yunsheng Ma; James R Hébert; Raji Balasubramanian; Nicole M Wedick; Barbara V Howard; Milagros C Rosal; Simin Liu; Chloe E Bird; Barbara C Olendzki; Judith K Ockene; Jean Wactawski-Wende; Lawrence S Phillips; Michael J Lamonte; Kristin L Schneider; Lorena Garcia; Ira S Ockene; Philip A Merriam; Deidre M Sepavich; Rachel H Mackey; Karen C Johnson; Joann E Manson
Journal:  Am J Epidemiol       Date:  2013-09-17       Impact factor: 4.897

9.  Type 2 diabetes and the risk of colorectal adenomas: Black Women's Health Study.

Authors:  Chiranjeev Dash; Julie R Palmer; Deborah A Boggs; Lynn Rosenberg; Lucile L Adams-Campbell
Journal:  Am J Epidemiol       Date:  2013-10-02       Impact factor: 4.897

10.  Racial and Ethnic Differences in Anthropometric Measures as Risk Factors for Diabetes.

Authors:  Juhua Luo; Michael Hendryx; Deepika Laddu; Lawrence S Phillips; Rowan Chlebowski; Erin S LeBlanc; David B Allison; Dorothy A Nelson; Yueyao Li; Milagros C Rosal; Marcia L Stefanick; JoAnn E Manson
Journal:  Diabetes Care       Date:  2018-10-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.